Qube Research & Technologies (QRT)’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$546K Sell
2,300
-3,500
-60% -$727K ﹤0.01% 2627
2026
Q1
$1.23M Buy
5,800
+3,700
+176% +$797K ﹤0.01% 2405
2025
Q4
$432K Buy
2,100
+200
+11% +$37.6K ﹤0.01% 2845
2025
Q3
$298K Buy
+1,900
New +$293K ﹤0.01% 2850
2023
Q4
Sell
-200
Closed -$17.4K 4364
2023
Q3
$17.4K Buy
+200
New +$18.1K ﹤0.01% 3187

Other funds holding CAH

Qube Research & Technologies (QRT)'s CAH Position: Q2 2026 in Review

Qube Research & Technologies (QRT) reduced its Cardinal Health (CAH) stake by 89% in Q2 2026, selling an estimated $188M and leaving 108,557 shares worth $25.8M. The position accounts for 0.02% of the portfolio, ranked #798.

Qube Research & Technologies (QRT) first reported a position in CAH in Q2 2018 and has held it in 21 quarters since. The position peaked at $239M in Q2 2025. 1,499 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • Qube Research & Technologies (QRT) held 108,557 shares of Cardinal Health worth $25.8M as of Q2 2026.
  • Qube Research & Technologies (QRT) sold 903,752 Cardinal Health shares in Q2 2026, an estimated $188M.
  • Cardinal Health made up 0.02% of Qube Research & Technologies (QRT)'s portfolio in Q2 2026, its #798 holding.
  • Qube Research & Technologies (QRT) first reported a position in Cardinal Health in Q2 2018 and has held it in 21 quarters since.
  • Qube Research & Technologies (QRT)'s Cardinal Health position peaked at $239M in Q2 2025.
  • 1,499 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.